Tumor-derived IL-6 may contribute to the immunological defect in CLL

Saved in:
Bibliographic Details
Published inLeukemia Vol. 22; no. 5; pp. 1084 - 1087
Main Authors Buggins, A G S, Patten, P E M, Richards, J, Thomas, N S B, Mufti, G J, Devereux, S
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.05.2008
Nature Publishing
Nature Publishing Group
Subjects
Biological and medical sciences
Cancer Research
Care and treatment
Chronic lymphocytic leukemia
Critical Care Medicine
Health aspects
Hematologic and hematopoietic diseases
Hematology
Humans
Immunology
Intensive
Interleukin 6
Interleukin-6 - immunology
Internal Medicine
letter-to-the-editor
Leukemia, Lymphocytic, Chronic, B-Cell - immunology
Leukemia, Lymphocytic, Chronic, B-Cell - pathology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Medicine
Medicine & Public Health
Neoplasm Proteins - immunology
Oncology
T-Lymphocytes - immunology
T-Lymphocytes - pathology
Tumors
United States
Interleukin 6
Chronic lymphocytic leukemia
Hematology
Lymphoproliferative syndrome
Cytokine
Tumor
Malignant hemopathy
Cancer
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0887-6924
1476-5551
DOI:10.1038/sj.leu.2405015